On Tuesday, CFRA analyst Paige Meyer raised the rating for Quest Diagnostics (NYSE:DGX) from Hold to Buy, increasing the price target to $178 from $155. The adjustment reflects the analyst's optimism ...
Commissions do not affect our editors' opinions or evaluations. Bars have unique point-of-sale (POS) system needs compared to retailers and other types of businesses. They need to be able to track ...
On Tuesday, CFRA analyst Paige Meyer raised the rating for Quest Diagnostics (NYSE:DGX) from Hold to Buy, increasing the price target to $178 from $155. The adjustment reflects the analyst's ...